Exchange: NASDAQ·Updated 07:30 PM EDT
Latest Earnings Results: Q2 '26

Reported: Jul 31

Estimated EPS

$0.44

Reported EPS

$0.46

Surprise

+4.55%

Estimated Rev

$20.35M

Reported Rev

$20.47M

Surprise

+0.57%

• Reported GAAP EPS of $0.41 down -8.89% YoY • Reported revenue of $20.47M up 0.28% YoY • For the third quarter of 2026, Iradimed expects revenue of $23.0 million to $24.5 million, GAAP diluted earnings per share of $0.49 to $0.54, and non-GAAP diluted earnings per share of $0.54 to $0.59.

Generated by Stocktwits using AI and company-reported earnings data for Q2 '26. This recap is intended to help readers understand the quarter quickly. Verify key figures in the linked source materials; the summary may contain errors and is not investment advice.

10-Q

Historical Earnings

Quarterly

Annual

EPS

Revenue

Fiscal PeriodEstimatedReportedSurpriseResult
Q3 '26
$0.55
--
--
N/A
Q2 '26
$0.44
$0.46
4.55%
BEAT
Q1 '26
$0.44
$0.49
10.11%
BEAT
Q4 '25
$0.48
$0.54
12.50%
BEAT
Q3 '25
$0.46
$0.47
3.30%
BEAT

Advertisement|Remove ads.